3Hye S J, Hyun JK, Chang WK,et al. Predictive factors for early clin- ical improvement after intra - arterial thrombolytic therapy in acute ischemic stroke [ J]. Journal of Stroke and Cerebrovascular Disea- ses,2014,23 (g) :283 - 289.
4Mamudu H M, Paul T, Veeranki S P, et al. Subclinical atherosclerosis and relationship with risk factors of coronary artery disease in a rural population[J]. Am J Med Sci, 2015 Sep 1.[Epub ahead of print] PubMed PMID:26332729.
5Abd ElHafeez S, Tripepi G, Mallamaci F, et al. Aldosterone, mortality, cardiovascular events and reverse epidemiology in end stage renal disease[J]. Eur J Clin Invest, 2015 Sep 6.[Epub ahead of print] PubMed PMID:26343265.
6Howard D P, Banerjee A, Fairhead J F, et al. A Population-based study of incidence, risk factors, outcome and prognosis of ischaemic peripheral arterial events:implications for prevention[J]. Circulation, 2015,[Epub ahead of print] PubMed PMID:26350058.
7Pang J, Poulter E B, Bell D A, et al. Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unit[J]. J Clin Lipidol, 2015, 9(5):703-708.
8Gong Z, Zhao D. Cardiovascular diseases and risk factors among Chinese immigrants[J]. Intern Emerg Med, 2015,[Epub ahead of print] PubMed PMID:26350421.
9Woo K S, Yip T W, Chook P, et al. Cardiovascular protective effects of adjunctive alternative medicine (Salvia Miltiorrhiza and Pueraria Lobata) in high-risk hypertension[J]. Evid Based Complement Alternat Med, 2013:132912. doi:10.1155/2013/132912.
10Cheung T T, Cheung B M. Managing blood pressure control in Asian patients:safety and efficacy of losartan[J]. Clin Interv Aging, 2014(9):443-450.
